Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling

  • Manuel A R Ferreira
  • , Rick Jansen
  • , Gonneke Willemsen
  • , Brenda W. Penninx
  • , Lisa M. Bain
  • , Cristina T. Vicente
  • , Joana A. Revez
  • , Melanie C. Matheson
  • , Jennie Hui
  • , Joyce Y. Tung
  • , Svetlana Baltic
  • , Peter Le Souëf
  • , Grant W. Montgomery
  • , Nicholas G. Martin
  • , Colin F. Robertson
  • , Alan James
  • , Philip J. Thompson
  • , Dorret I. Boomsma
  • , John L. Hopper
  • , David A. Hinds
  • Rhiannon B. Werder, Simon Phipps, Australian Asthma Genetics Consortium Collaborators

Research output: Contribution to journalArticlepeer-review

320 Downloads (Pure)

Abstract

Background Hundreds of genetic variants are thought to contribute to variation in asthma risk by modulating gene expression. Methods that increase the power of genome-wide association studies (GWASs) to identify risk-associated variants are needed. Objective We sought to develop a method that aggregates the evidence for association with disease risk across expression quantitative trait loci (eQTLs) of a gene and use this approach to identify asthma risk genes. Methods We developed a gene-based test and software package called EUGENE that (1) is applicable to GWAS summary statistics; (2) considers both cis- and trans-eQTLs; (3) incorporates eQTLs identified in different tissues; and (4) uses simulations to account for multiple testing. We applied this approach to 2 published asthma GWASs (combined n = 46,044) and used mouse studies to provide initial functional insights into 2 genes with novel genetic associations. Results We tested the association between asthma and 17,190 genes that were found to have cis- and/or trans-eQTLs across 16 published eQTL studies. At an empirical FDR of 5%, 48 genes were associated with asthma risk. Of these, for 37, the association was driven by eQTLs located in established risk loci for allergic disease, including 6 genes not previously implicated in disease cause (eg, LIMS1, TINF2, and SAFB). The remaining 11 significant genes represent potential novel genetic associations with asthma. The association with 4 of these replicated in an independent GWAS: B4GALT3, USMG5, P2RY13, and P2RY14, which are genes involved in nucleotide synthesis or nucleotide-dependent cell activation. In mouse studies, P2ry13 and P2ry14—purinergic receptors activated by adenosine 5-diphosphate and UDP-sugars, respectively—were upregulated after allergen challenge, notably in airway epithelial cells, eosinophils, and neutrophils. Intranasal exposure with receptor agonists induced the release of IL-33 and subsequent eosinophil infiltration into the lungs. Conclusion We identified novel associations between asthma and eQTLs for 4 genes related to nucleotide synthesis/signaling and demonstrated the power of gene-based analyses of GWASs.

Original languageEnglish
Pages (from-to)1148-1157
Number of pages10
JournalJournal of Allergy and Clinical Immunology
Volume139
Issue number4
DOIs
Publication statusPublished - 1 Apr 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling'. Together they form a unique fingerprint.

Cite this